These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 12404669)

  • 1. Tolerability and safety aspects of mirtazapine.
    Nutt DJ
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
    Nutt DJ
    Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacologic profile of mirtazapine.
    de Boer T
    J Clin Psychiatry; 1996; 57 Suppl 4():19-25. PubMed ID: 8636062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.
    Stimmel GL; Dopheide JA; Stahl SM
    Pharmacotherapy; 1997; 17(1):10-21. PubMed ID: 9017762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine: pharmacology in relation to adverse effects.
    Nutt D
    Acta Psychiatr Scand Suppl; 1997; 391():31-7. PubMed ID: 9265949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and patient compliance.
    Roose SP
    J Clin Psychiatry; 1999; 60 Suppl 17():14-7; discussion 46-8. PubMed ID: 10446736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and safety: essentials in antidepressant pharmacotherapy.
    Lader MH
    J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine augmentation in the treatment of refractory depression.
    Carpenter LL; Jocic Z; Hall JM; Rasmussen SA; Price LH
    J Clin Psychiatry; 1999 Jan; 60(1):45-9. PubMed ID: 10074878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.
    Kakui N; Yokoyama F; Yamauchi M; Kitamura K; Imanishi T; Inoue T; Koyama T
    Pharmacol Biochem Behav; 2009 May; 92(3):393-8. PubMed ID: 19167420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
    Hieber R; Dellenbaugh T; Nelson LA
    Ann Pharmacother; 2008 Jun; 42(6):841-6. PubMed ID: 18460588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
    Fawcett J; Barkin RL
    J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
    Kent JM
    Lancet; 2000 Mar; 355(9207):911-8. PubMed ID: 10752718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine: a review of its clinical efficacy and tolerability.
    Szegedi A; Schwertfeger N
    Expert Opin Pharmacother; 2005 Apr; 6(4):631-41. PubMed ID: 15934889
    [No Abstract]   [Full Text] [Related]  

  • 17. Mirtazapine-induced akathisia.
    Gulsun M; Doruk A
    J Clin Psychopharmacol; 2008 Aug; 28(4):467. PubMed ID: 18626283
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertensive urgency induced by an interaction of mirtazapine and clonidine.
    Abo-Zena RA; Bobek MB; Dweik RA
    Pharmacotherapy; 2000 Apr; 20(4):476-8. PubMed ID: 10772378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of action of antidepressants: results of different analyses.
    Thompson C
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S27-32. PubMed ID: 12404667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.